The content on this page is designed for Australia. Check courses designed for Canada (EN)

This course has expired. View available courses.

Cardiovascular

The evolving role of NT-proBNP in diagnosis and monitoring of heart failure

Natriuretic peptides (NPs) are released from the heart in response to haemodynamic stimuli including atrial stretch and NT-proBNP has diagnostic and prognostic value in patients with acute and chronic heart failure, with high specificity and well validated cut-off values.

As the population ages and co-morbidities increase, HF prevalence, related hospital admissions and mortality are expected to continue rising.3 Diagnostic uncertainty is often high after initial evaluation of dyspnoeic patients, as the clinical presentation and physical findings associated with HF are common and non- specific. Early NT-proBNP testing has an important role in diagnosis, allowing clinicians to identify patients with a high risk of HF and refer them promptly for echocardiography when appropriate.

There is an evolving role for NT-proBNP testing in guiding individualised HF management decisions such as timing of hospital discharge, and monitoring of outpatients to detect early evidence of decompensation, with a view to optimising therapy and reducing re-admissions. Clinical guidelines reflect the evidence for the utility of NT-proBNP testing in the acute and chronic HF settings, with some differences between Australian and European guidelines and reimbursement, which may present a practical barrier in some circumstances.


This educational activity was developed by MdBriefCase, with funding from Roche Diagnostics.

DURATION

15 min

PROFESSION

Physician, Specialist

# OF CREDITS

0

ACCREDITATION

Unaccredited

EXPIRY DATE

2023-01-25

Natriuretic peptides (NPs) are released from the heart in response to haemodynamic stimuli including atrial stretch and NT-proBNP has diagnostic and prognostic value in patients with acute and chronic heart failure, with high specificity and well validated cut-off values.

As the population ages and co-morbidities increase, HF prevalence, related hospital admissions and mortality are expected to continue rising.3 Diagnostic uncertainty is often high after initial evaluation of dyspnoeic patients, as the clinical presentation and physical findings associated with HF are common and non- specific. Early NT-proBNP testing has an important role in diagnosis, allowing clinicians to identify patients with a high risk of HF and refer them promptly for echocardiography when appropriate.

There is an evolving role for NT-proBNP testing in guiding individualised HF management decisions such as timing of hospital discharge, and monitoring of outpatients to detect early evidence of decompensation, with a view to optimising therapy and reducing re-admissions. Clinical guidelines reflect the evidence for the utility of NT-proBNP testing in the acute and chronic HF settings, with some differences between Australian and European guidelines and reimbursement, which may present a practical barrier in some circumstances.


This educational activity was developed by MdBriefCase, with funding from Roche Diagnostics.

Faculty

Professor Andrew Sindone, B. Med (Hons), MD, FRACP, FCSANZ, FNHFA

New South Wales

Learning objectives

Understand the medical value of the NT-proBNP diagnostic test in clinical practice:

  1. To aid in diagnosis of acute and chronic heart failure
  2. To aid in hospital discharge planning for heart failure patients
  3. To help monitor heart failure patients
  4. To help identify those type 2 diabetes patients at greater risk of CVD
Cost of course:  
Free
# of credits: 0
Duration: 15 min

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.